DCIS

This study is testing whether women with a specific, very low-risk type of early breast cancer (DCIS) can safely skip whole-breast radiation after breast-conserving surgery. It aims to identify patients who are unlikely to have the cancer return, allowing them to avoid the side e…

This large study is testing whether active monitoring (watchful waiting) is as safe and effective as surgery for women with a very early, low-risk form of breast cancer called DCIS. It aims to see if avoiding surgery can prevent unnecessary treatment and side effects like chronic…

This study is testing whether giving targeted radiation to part of the breast before surgery is a safe and feasible approach for early-stage breast cancer. It will enroll about 98 patients to see if this timing leads to fewer wound problems and better cosmetic outcomes compared t…

This study is testing a new fluorescent dye called LS301-IT. It is given by IV before surgery to help surgeons see the edges of breast cancer tissue and nearby lymph nodes more clearly. The main goals are to check if the dye is safe and to see how well it helps guide surgery for …

This study aims to find out if a 'watchful waiting' approach is as safe as immediate surgery or radiation for women with certain early, non-invasive breast cell changes (low-risk DCIS). It will follow 2,500 women for 10 years, comparing those who choose active monitoring with ann…